Assessing Cell-Specific Delivery and Efficacy of Therapeutic Oligonucleotides Using Combined RNAscope Plus and

Louis Szeponik1

  • 1AstraZeneca, R&D, Clinical Pharmacology and Safety Sciences, Integrated Bioanalysis, Mölndal, Sweden. lszeponik@gmail.com.

Related Concept Videos